10-Q 1 y99949e10vq.txt FORM 10-Q . . . UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 --------------------- FORM 10-Q EQUIVALENT(1) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2004 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. FOR THE TRANSITION PERIOD FROM TO .
COMMISSION FILE NUMBER 333-80337 --------------------- TEAM HEALTH, INC. (Exact name of registrant as specified in its charter) TENNESSEE 62-1562558 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification Number)
1900 WINSTON ROAD SUITE 300 KNOXVILLE, TENNESSEE 37919 (865) 693-1000 (Address, zip code, and telephone number, including area code, of registrant's principal executive office.) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 and 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2) Yes [ ] No [X] Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date. Common Stock par value $0.01 per share -- 9,797,555 shares as of August 6, 2004. --------------- (1) This Form 10-Q Equivalent is only being filed solely pursuant to a requirement contained in the indenture governing Team Health, Inc.'s 9% Senior Subordinated Notes due 2012. FORWARD LOOKING STATEMENTS Statements in this document that are not historical facts are hereby identified as "forward looking statements" for the purposes of the safe harbor provided by Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act") and Section 27A of the Securities Act of 1933 (the "Securities Act"). Team Health, Inc. (the "Company") cautions readers that such "forward looking statements", including without limitation, those relating to the Company's future business prospects, revenue, working capital, professional liability expense, liquidity, capital needs, interest costs and income, wherever they occur in this document or in other statements attributable to the Company, are necessarily estimates reflecting the judgment of the Company's senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the "forward looking statements". Such "forward looking statements" should, therefore, be considered in light of the factors set forth in "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations". The "forward looking statements" contained in this report are made under the caption "Management's Discussion and Analysis of Financial Condition and Results of Operations". Moreover, the Company, through its senior management, may from time to time make "forward looking statements" about matters described herein or other matters concerning the Company. The Company disclaims any intent or obligation to update "forward looking statements" to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time. TEAM HEALTH, INC. QUARTERLY REPORT FOR THE THREE MONTHS ENDED JUNE 30, 2004
PAGE ---- Part 1. Financial Information Item 1. Financial Statements (Unaudited) Consolidated Balance Sheets -- June 30, 2004 and December 31, 2003.................................................... 2 Consolidated Statements of Operations -- Three months ended June 30, 2004 and 2003...................................... 3 Consolidated Statements of Operations -- Six months ended June 30, 2004 and 2003...................................... 4 Consolidated Statements of Cash Flows -- Six months ended June 30, 2004 and 2003...................................... 5 Notes to Consolidated Financial Statements.................. 6 Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations................................... 14 Item 3. Quantitative and Qualitative Disclosures About Market Risk........................................................ 24 Item 4. Controls and Procedures..................................... 25 Part 2. Other Information Item 1. Legal Proceedings........................................... 26 Item 2. Changes in Securities and Use of Proceeds................... 26 Item 3. Defaults Upon Senior Securities............................. 26 Item 4. Submission of Matters to a Vote of Security Holders......... 26 Item 5. Other Information........................................... 26 Item 6. Exhibits and Reports on Form 8-K............................ 26 Signatures................................................................... 27
1 PART 1. FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS TEAM HEALTH, INC. CONSOLIDATED BALANCE SHEETS
JUNE 30, DECEMBER 31, 2004 2003 ----------- ------------ (UNAUDITED) (IN THOUSANDS, EXCEPT PER SHARE DATA) ASSETS Current assets: Cash and cash equivalents................................. $ 54,971 $ 100,964 Accounts receivable, net.................................. 152,002 167,957 Prepaid expenses and other current assets................. 18,258 4,243 Receivables under insured programs........................ 51,882 62,527 --------- --------- Total current assets........................................ 277,113 335,691 Property and equipment, net................................. 17,896 19,967 Other intangibles, net...................................... 14,307 16,990 Goodwill.................................................... 102,555 167,665 Deferred income taxes....................................... 102,128 96,881 Receivables under insured programs.......................... 51,487 60,697 Other....................................................... 33,400 33,158 --------- --------- $ 598,886 $ 731,049 ========= ========= LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Current liabilities: Accounts payable.......................................... $ 12,747 $ 15,169 Accrued compensation and physician payable................ 70,988 76,557 Other accrued liabilities................................. 69,080 82,876 Income taxes payable...................................... 8,195 9,948 Current maturities of long-term debt...................... 2,500 43,528 Deferred income taxes..................................... 20,372 20,884 --------- --------- Total current liabilities................................... 183,882 248,962 Long-term debt, less current maturities..................... 426,875 255,887 Other non-current liabilities............................... 191,874 182,557 Mandatory redeemable preferred stock........................ -- 158,846 Commitments and Contingencies Common stock, $0.01 par value 12,000 shares authorized, 10,081 shares issued at June 30, 2004 and 10,069 shares issued at December 31, 2003............................... 101 101 Additional paid in capital.................................. 755 703 Retained earnings (deficit)................................. (200,953) (113,813) Less -- treasury shares at cost............................. (3,532) (1,045) Accumulated other comprehensive loss........................ (116) (1,149) --------- --------- $ 598,886 $ 731,049 ========= =========
See accompanying notes to financial statements 2 TEAM HEALTH, INC CONSOLIDATED STATEMENTS OF OPERATIONS
THREE MONTHS ENDED JUNE 30, ------------------- 2004 2003 -------- -------- (UNAUDITED) (IN THOUSANDS) Net revenue................................................. $388,730 $358,979 Provision for uncollectibles................................ 132,736 108,848 -------- -------- Net revenue less provision for uncollectibles............. 255,994 250,131 Cost of services rendered Professional service expenses............................. 191,237 187,001 Professional liability costs.............................. 13,617 14,535 -------- -------- Gross profit........................................... 51,140 48,595 General and administrative expenses......................... 24,124 24,460 Management fee and other expenses........................... 457 128 Depreciation and amortization............................... 3,459 5,598 Interest expense, net....................................... 7,008 6,178 Estimated impairment loss................................... 65,819 -- -------- -------- Earnings (loss) before income taxes.................... (49,727) 12,231 Provision for income taxes.................................. 6,190 4,553 -------- -------- Net earnings (loss)......................................... (55,917) 7,678 Dividends on preferred stock................................ -- 3,600 -------- -------- Net earnings (loss) attributable to common stockholders... $(55,917) $ 4,078 ======== ========
See accompanying notes to financial statements. 3 TEAM HEALTH, INC. CONSOLIDATED STATEMENTS OF OPERATIONS
SIX MONTHS ENDED JUNE 30, ------------------- 2004 2003 -------- -------- (UNAUDITED) (IN THOUSANDS) Net revenue................................................. $786,032 $709,118 Provision for uncollectibles................................ 268,628 220,573 -------- -------- Net revenue less provision for uncollectibles............. 517,404 488,545 Cost of services rendered Professional service expenses............................. 385,948 368,997 Professional liability costs.............................. 29,891 76,078 -------- -------- Gross profit........................................... 101,565 43,470 General and administrative expenses......................... 48,819 45,923 Management fee and other expenses........................... 613 253 Depreciation and amortization............................... 6,944 11,121 Interest expense, net....................................... 14,326 12,393 Refinancing costs........................................... 14,731 -- Estimated impairment loss................................... 65,819 -- -------- -------- Loss before income taxes............................... (49,687) (26,220) Provision (benefit) for income taxes........................ 6,266 (9,089) -------- -------- Net loss.................................................... (55,953) (17,131) Dividends on preferred stock................................ 3,602 7,161 -------- -------- Net loss attributable to common stockholders.............. $(59,555) $(24,292) ======== ========
See accompanying notes to financial statements. 4 TEAM HEALTH, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS
SIX MONTHS ENDED JUNE 30, --------------------- 2004 2003 --------- --------- (UNAUDITED) (IN THOUSANDS) OPERATING ACTIVITIES Net loss.................................................... $ (55,953) $ (17,131) Adjustments to reconcile net earnings (loss) to net cash provided by operating activities: Depreciation and amortization............................. 6,944 11,121 Amortization of deferred financing costs.................. 549 714 Refinancing costs......................................... 6,225 -- Estimated impairment loss................................. 65,819 -- Provision for uncollectibles.............................. 268,628 220,573 Deferred income taxes..................................... (6,385) (17,032) Loss on sale of equipment................................. 362 3 Equity in joint venture income............................ (565) (91) Changes in operating assets and liabilities, net of acquisitions: Accounts receivable....................................... (252,566) (227,140) Prepaid expenses and other current assets................. (20,214) (2,799) Income taxes payable...................................... (1,752) 7,118 Receivables under insured programs........................ 19,855 9,040 Accounts payable.......................................... (2,422) (1,644) Accrued compensation and physician payable................ (12,681) 2,077 Other accrued liabilities................................. (1,640) (2,037) Professional liability reserves........................... 7,204 28,952 --------- --------- Net cash provided by operating activities................... 21,408 11,724 INVESTING ACTIVITIES Purchases of property and equipment......................... (2,557) (5,891) Cash paid for acquisitions, net............................. (2,259) (1,571) Purchase of investments..................................... (2,006) (1,864) Other investing activities.................................. 9,402 (960) --------- --------- Net cash provided by (used in) investing activities......... 2,580 (10,286) FINANCING ACTIVITIES Payments on notes payable................................... (300,040) (15,090) Proceeds from notes payable................................. 430,000 -- Payment of deferred financing costs......................... (7,446) (51) Proceeds from sales of common stock......................... 47 -- Purchase of treasury stock.................................. (2,609) -- Proceeds from sale of treasury stock........................ 100 Dividends paid on common shares............................. (27,585) -- Redemption of preferred shares.............................. (162,448) -- --------- --------- Net cash used in financing activities....................... (69,981) (15,141) --------- --------- Net decrease in cash........................................ (45,993) (13,703) Cash and cash equivalents, beginning of period.............. 100,964 47,789 --------- --------- Cash and cash equivalents, end of period.................... $ 54,971 $ 34,086 ========= ========= Interest paid............................................... $ 15,325 $ 11,639 ========= ========= Taxes paid.................................................. $ 14,755 $ 1,079 ========= =========
See accompanying notes to financial statements. 5 TEAM HEALTH, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) NOTE 1. BASIS OF PRESENTATION The accompanying unaudited consolidated financial statements include the accounts of Team Health, Inc. (the "Company") and its wholly owned subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States for interim financial reporting and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by accounting principles generally accepted in the United States for complete financial statements. Certain prior year amounts have been reclassified to conform to the current year presentation. In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments (consisting of normal recurring items) necessary for a fair presentation of results for the interim periods presented. The results of operations for any interim period are not necessarily indicative of results for the full year. The consolidated balance sheet of the Company at December 31, 2003 has been derived from the audited financial statements at that date, but does not include all of the information and disclosures required by accounting principles generally accepted in the United States for complete financial statements. These financial statements and footnote disclosures should be read in conjunction with the December 31, 2003 audited consolidated financial statements and the notes thereto included in the Company's Form 10-K Equivalent. The preparation of the financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the accompanying consolidated financial statements and notes. Actual results could differ from those estimates. Our business of providing healthcare staffing comprises a single reportable segment under Statement of Financial Accounting Standards (SFAS) No. 131, Disclosures About Segments of an Enterprise and Related Information. NOTE 2. IMPLEMENTATION OF NEW ACCOUNTING STANDARDS On December 31, 2002, the Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards (SFAS) No. 148, Accounting for Stock-Based Compensation -- Transition and Disclosure. SFAS No. 148 amends SFAS No. 123, Accounting for Stock-Based Compensation, to provide alternative methods of transition to the fair value method of accounting for stock-based employee compensation under SFAS No. 123. SFAS No. 148 also amends the disclosure provisions of SFAS No. 123 and APB Opinion No. 28, Interim Financial Reporting, to require disclosure in the summary of significant accounting policies of the effects of an entity's accounting policy with respect to stock-based employee compensation on reported earnings in annual and interim financial statements. While the Statement does not amend SFAS No. 123 to require companies to account for employee stock options using the fair value method, the disclosure provisions of SFAS No. 148 are applicable to all companies with stock-based employee compensation, regardless of whether the accounting for that compensation is using the fair value method of SFAS No. 123 or the intrinsic value method of Opinion 25. As more fully discussed in Note 10, the Company adopted the disclosure requirements of SFAS No. 148 and the fair value recognition provisions of SFAS No. 123, Accounting for Stock-Based Compensation, prospectively to all new awards granted to employees after January 1, 2003. 6 TEAM HEALTH, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) NOTE 3. NET REVENUE Net revenue for the three and six months ended June 30, 2004 and 2003, respectively, consisted of the following (in thousands):
THREE MONTHS ENDED SIX MONTHS ENDED JUNE 30, JUNE 30, ------------------- ------------------- 2004 2003 2004 2003 -------- -------- -------- -------- Fee for service revenue.................... $280,222 $245,511 $565,161 $491,930 Contract revenue........................... 100,803 104,743 205,835 201,451 Other revenue.............................. 7,705 8,725 15,036 15,737 -------- -------- -------- -------- $388,730 $358,979 $786,032 $709,118 ======== ======== ======== ========
NOTE 4. IMPAIRMENT OF GOODWILL During the six months ended June 30, 2004, the Company derived approximately $123.9 million of revenue for services rendered to military personnel and their dependents as a subcontractor under the TRICARE program administered by the Department of Defense. Civilian staffing for the provision of health care services provided under the TRICARE program is provided through several different sources, including the direct hiring of health care related personnel by the military, contracting with managed care support contractors to provide health, medical and administrative support services to its eligible beneficiaries, and through direct contracting with health care staffing organizations. The Company has historically provided its services principally through subcontract arrangements with managed care organizations that have contracted directly with the TRICARE program. On August 1, 2002, the Department of Defense issued a request for proposals for the next generation of managed care support contracts, also known as the "TRICARE Contracts". The intent of the TRICARE Contracts is to replace the existing managed care support contracts on a phased-in basis between June 1 and November 1, 2004. The Department of Defense and its various military branches are currently in the process of procuring the civilian positions that they require going forward. The process of awarding healthcare staffing contracts by the government to date has varied by branch of the military and by military base. The award process has included soliciting requests for proposals from organizations that provide civilian health care staffing, including the use of restrictive government or military approved vendor lists, some of which do not include the Company. In other instances, the military has re-bid its business on a basis that is inclusive of existing providers, such as the Company, without the use of restricted vendor lists. Furthermore, the awarding of certain bids has been restricted to small business or minority qualified businesses for which the Company is not eligible to even bid for the contracts. As of July 15, 2004, the following is a summary of the Company's military staffing revenues that are subject to re-bidding under the new TRICARE program contracting process (in thousands): Annual revenue derived from contracts subject to re-bidding................................................ $210,700 Amount of revenue re-bid to date............................ $145,200 Amount of annual revenues submitted for re-bidding awarded to date................................................... $132,600 Annual revenue value of bids won to date (including new business of $26.5 million)................................ $ 93,500 Percentage of revenue retained or new business won to total of annual revenue re-bidded and awarded to date........... 71%
The total impact on the results of operations and financial condition of the Company resulting from the changes in the TRICARE Contracts program is not known at this time. The remaining estimated impact on 7 TEAM HEALTH, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) the results of operations of the Company is dependent on the Company's ability to successfully retain its existing staffing business that is still subject to the re-bidding process, as well as winning new business as it is put out to bid by the military. In addition, the Company will experience as a result of the re-bidding process a decline in its operating margins for its military business prior to any reductions in related administrative related expenses. Management has concluded that the Company's existing revenues and operating margins will be materially adversely affected as a result of the re-bidding process. The Company as of June 30, 2004, had $127.9 million of goodwill related to its military staffing business prior to recognition of any impairment loss related to it. Based on the results of the re-bidding process known through July 15, 2004, along with projections of the estimated results of the remaining business to be subject to re-bidding, management has concluded that a portion of such goodwill has been impaired. The Company has recorded an estimated goodwill impairment loss based on the fair value of comparable healthcare staffing companies. The amount of estimated goodwill impairment loss recorded in the three months ended June 30, 2004 was $65.8 million. A final determination of the impairment loss will be known following the completion of the re-bidding process which is scheduled to be completed by November 1, 2004. The estimated impairment loss will be adjusted, if necessary, when such final determination is known later in 2004. NOTE 5. OTHER INTANGIBLE ASSETS The following is a summary of intangible assets and related amortization as of June 30, 2004 and December 31, 2003 (in thousands):
GROSS CARRYING ACCUMULATED AMOUNT AMORTIZATION -------------- ------------ As of June 30, 2004: Contracts................................................ $35,614 $21,558 Other.................................................... 448 197 ------- ------- Total................................................. $36,062 $21,755 ======= ======= As of December 31, 2003: Contracts................................................ $35,614 $18,898 Other.................................................... 448 174 ------- ------- Total................................................. $36,062 $19,072 ======= ======= Aggregate amortization expense: For the three months ended June 30, 2004................. $ 1,341 ======= For the six months ended June 30, 2004................... $ 2,683 ======= Estimated amortization expense: For the year ended December 31, 2004..................... $ 5,365 For the year ended December 31, 2005..................... 4,147 For the year ended December 31, 2006..................... 2,582 For the year ended December 31, 2007..................... 2,151 For the year ended December 31, 2008..................... 1,798
As of June 30, 2004, the Company may have to pay up to $8.4 million in future contingent payments as additional consideration for acquisitions made prior to June 30, 2004. These payments will be made and recorded as additional goodwill should the acquired operations achieve the financial targets agreed to in the 8 TEAM HEALTH, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) respective acquisition agreements. During the six months ended June 30, 2004, the Company made $2.3 million cash payments related to previous acquisitions. NOTE 6. PROFESSIONAL LIABILITY INSURANCE The Company provides for its estimated professional liability losses through a combination of self-insurance and commercial insurance programs. Beginning March 12, 2003, such risks are principally being provided for through a self-insurance program with a portion of such risks ("claims-made" basis) transferred to and funded into a captive insurance company. The accounts of the captive insurance company are fully consolidated with those of the other operations of the Company in the accompanying financial statements. The self-insurance program includes reserves for future claims incurred but not reported. The Company's provisions for losses under the self-insurance program are estimated using the results of periodic actuarial studies performed by an independent actuarial firm. Such actuarial studies include numerous underlying estimates and assumptions, including assumptions as to future claim losses, the severity and frequency of such projected losses, loss development factors and others. During the three months ended June 30, 2004, the Company reduced loss estimates totaling $2.0 million recorded in prior years for professional liability claims in excess of commercially insured limits. An ongoing review of claims related to such loss estimates has now resulted in the conclusion that such claims are more likely than not to be settled or dismissed so as to result in no loss to the Company in excess of insured amounts for the applicable periods. The conclusion reached in the period was based on the time elapsed from the insured periods, the settlement of certain claims at amounts less than insured limits and a review of remaining claims by both the Company's risk managers and third-party claim examiners for the estimated dollar level exposure for reported claims. During the period March 12, 1999 through March 11, 2003, the primary source of the Company's coverage for such risks was a professional liability insurance policy provided through one insurance carrier. The policy with the Company's primary insurance carrier for such coverage and period provided coverage for potential liabilities on a "claims-made" basis. The policy included the ability for the Company to be able to exercise a "tail" premium option. The option for the tail premium was exercised by the Company effective March 11, 2003, and its cost of approximately $30.6 million, was paid in April 2003. The Company had previously recorded the cost of such option over the four-year period ended March 11, 2003. The tail premium option included an aggregate limit of $130.0 million that included claims reported during the two-year period ended March 12, 2003, as well as all incurred but not reported claims during the period March 12, 1999 to March 11, 2003. An actuarial study of the Company's potential loss exposure under the aggregate limit of $130.0 million done prior to exercising the tail premium resulted in the Company recording a provision in the three months ended March 31, 2003 of $50.8 million for projected losses in excess of the aggregate limit. Such loss estimate was net of a discount of 4% over the projected future payment periods The Company's provisions for losses subsequent to March 11, 2003, that are not covered by commercial insurance company coverage are subject to subsequent adjustment should future actuarial projected results for such periods indicate projected losses are greater or less than previously projected. In addition, the results of future actuarial studies may result in the loss estimate provision under the aggregate policy limit to be further adjusted upward or downward as actual results are realized over time. 9 TEAM HEALTH, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) NOTE 7. LONG-TERM DEBT Long-term debt as of June 30, 2004, consisted of the following (in thousands): Term Loan B................................................. $249,375 9% Senior Subordinated Notes................................ 180,000 -------- 429,375 Less current portion........................................ 2,500 -------- $426,875 ========
The Company's senior credit facilities consist of the following: - $80.0 million Senior Secured Revolving Credit Facility - $249.4 million Senior Secured Term Loan B The interest rates for any senior revolving credit facility borrowings are determined by reference to a grid that is based on the consolidated ratio of total funded debt to earnings before interest, taxes, depreciation and amortization (EBITDA), as defined in the credit agreement. The interest rate on the Term Loan B amount outstanding is equal to the euro dollar rate plus 3.25% or the agent bank's base rate plus 1.75%. The interest rate at June 30, 2004, was 4.84% for the Term Loan B. The Company also pays a commitment fee for the revolving credit facility which was equal to 0.5% of the commitment at June 30, 2004. No funds have been borrowed under the revolving credit facility as of June 30, 2004, but the Company had $3.9 million of standby letters of credit outstanding against the revolving credit facility commitment. The Company has an obligation under the terms of the senior credit facility agreement to obtain and maintain interest rate hedge agreements at amounts such that 50% of the Company's funded debt, as defined, was at fixed rates of interest. Such hedge agreements are required to be maintained for at least the first three years of the senior credit facility agreement. On April 29, 2004, the Company entered into an interest rate swap agreement that effectively converted $35.0 million of its variable rate Term B loan to a fixed rate of 3.2% through March 31, 2007. The Company issued on March 23, 2004, 9% Senior Subordinated Notes in the amount of $180.0 million, due April 1, 2012. Aggregate maturities of long-term debt due within one year of June 30, 2004 are currently as follows (in thousands): 2005........................................................ $ 2,500 2006........................................................ 2,500 2007........................................................ 2,500 2008........................................................ 2,500 Thereafter.................................................. 419,375 -------- $429,375 ========
The senior credit facility agreement and the 9% bond indenture contain both affirmative and negative covenants, including limitations on the Company's ability to incur additional indebtedness, sell material assets, retire, redeem or otherwise reacquire its capital stock, acquire the capital stock or assets of another business, pay dividends, and requires the Company to meet or exceed certain coverage and leverage ratios. In addition, the senior credit agreement includes a provision for the prepayment of a portion of the outstanding term loan amounts at any year-end if the Company generates "excess cash flow" as defined in the agreement. 10 TEAM HEALTH, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) Effective March 23, 2004, the Company completed a tender offer for its then outstanding 12% Senior Subordinated Notes in the amount of $100.0 million, plus a call premium of $8.0 million and entered into its current senior credit facilities with a group of banks. As a result of the tender offer, approximately $91.7 million of the 12% Senior Subordinated Notes were repaid and in addition a related call premium of approximately $7.5 million was paid on March 23, 2004. The remainder of the approximately $8.3 million 12% Senior Subordinated Notes outstanding were subsequently repaid on April 21, 2004, along with a call premium of approximately $0.7 million. As a result of entering into the new senior credit facilities and the redemption of its 12% Subordinated Notes, the Company recognized in the six months ended June 30, 2004, refinancing costs of approximately $14.7 million ($9.0 million net of related income tax benefit of $5.7 million) principally relating to the write-off of capitalized financing costs on its previously outstanding long-term debt and the incurrence of the call premium to redeem the 12% Senior Subordinated Notes. In addition, as a result of repayment of underlying borrowings during the three months ended March 31, 2004, the Company recorded as additional interest expense approximately $1.7 million in the three months ended March 31, 2004, related to an interest rate swap agreement to reflect its value on a mark-to-market basis. The interest rate swap agreement was terminated subsequent to March 31, 2004. NOTE 8. REDEMPTION OF 10% CUMULATIVE PREFERRED STOCK During the three months ended March 31, 2004, the Board of Directors of the Company authorized the redemption of the Company's 10% Cumulative Preferred Stock. On March 23, 2004, the Company redeemed its 10% Cumulative Preferred Stock in the amount of approximately $162.4 million, including accrued dividends. NOTE 9. COMMON STOCK DIVIDEND AND RELATED COMPENSATORY BONUS PAYMENT The Company's Board of Directors declared a cash dividend to shareholders of record as of March 18, 2004, in the amount of approximately $27.6 million which was subsequently paid on March 23, 2004. The Board of Directors also authorized a compensatory payment to holders of stock options in lieu of a cash dividend in the amount of approximately $2.4 million of which $1.3 million was paid and expensed on March 23, 2004, with the balance of $1.1 million to be paid and expensed in future periods as such stock options vest. NOTE 10. STOCK OPTIONS Effective January 1, 2003, the Company adopted the fair value recognition provisions of SFAS No. 123, Accounting for Stock-Based Compensation, prospectively to all new awards granted to employees after January 1, 2003. Prior to January 1, 2003 the Company applied the recognition and measurement provisions of APB Opinion No. 25, Accounting for Stock Issued to Employees, and related Interpretations in accounting for options awarded. Therefore, the expense related to stock-based employee compensation included in the determination of net earnings (loss) for the three and six months ended June 30, 2004 and 2003 is less than that which would have been recognized if the fair value method had been applied to all awards. The following 11 TEAM HEALTH, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) table illustrates the effect on net earnings (loss) if the fair value method had been applied to all outstanding and unvested awards in each period (in thousands):
THREE MONTHS ENDED SIX MONTHS ENDED JUNE 30, JUNE 30, ------------------- ------------------- 2004 2003 2004 2003 --------- ------- -------- -------- Net earnings (loss) attributable to common stockholders, as reported.................. $(55,917) $4,078 $(59,555) $(24,292) Add: Stock-based employee compensation expense included in reported net loss attributable to common stockholders, net of related tax effects........................ 7 4 16 6 Deduct: Total stock-based employee compensation expense determined under the fair value method for all awards, net of related tax effects........................ (41) (24) (80) (47) -------- ------ -------- -------- Pro forma net earnings (loss) attributable to common stockholders........................ $(55,951) $4,058 $(59,619) $(24,333) ======== ====== ======== ========
NOTE 11. CONTINGENCIES LITIGATION We are party to various pending legal actions arising in the ordinary operation of our business such as contractual disputes, employment disputes and general business actions as well as professional liability actions. We believe that any payment of damages resulting from these types of lawsuits would be covered by insurance, exclusive of deductibles, would not be in excess of related reserves, and such liabilities, if incurred, should not have a significant negative effect on the results of operations and financial condition of our Company. INDEMNITY In connection with the acquisition of a company that specializes in providing medical staff providers to military treatment facilities on May 1, 2002, subject to certain limitations, the previous shareholders of such company and its related entities have indemnified the Company up to a limit of $10.0 million relating to any potential claims asserted against the acquired company during the three years subsequent to the date of its acquisition related to tax matters whose origin was attributable to tax periods prior to May 1, 2002. HEALTHCARE REGULATORY MATTERS Laws and regulations governing the Medicare and Medicaid programs are complex and subject to interpretation. Compliance with such laws and regulations can be subject to future governmental review and interpretation as well as significant regulatory action. From time to time, governmental regulatory agencies will conduct inquiries and audits of the Company's practices. It is the Company's current practice and future intent to cooperate fully with such inquiries. In addition to laws and regulations governing the Medicare and Medicaid programs, there are a number of federal and state laws and regulations governing such matters as the corporate practice of medicine and fee splitting arrangements, anti-kickback statutes, physician self-referral laws, false or fraudulent claims filing and patient privacy requirements. The failure to comply with any of such laws or regulations could have an adverse impact on our operations and financial results. It is management's belief that the Company is in substantial compliance in all material respects with such laws and regulations. 12 TEAM HEALTH, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS -- (CONTINUED) ACQUISITION PAYMENTS As of June 30, 2004, the Company may have to pay up to $8.4 million in future contingent payments as additional consideration for acquisitions made prior to June 30, 2004. These payments will be made and recorded as additional purchase price should the acquired operations achieve the financial targets agreed to in the respective acquisition agreements. OFFICE OF INSPECTOR GENERAL INFORMATION REQUEST On March 30, 2004, the Company received a subpoena from the Department of Health and Human Services Office of Inspector General ("OIG") located in Concord, California requesting certain information for the period 1999 to present relating to the Company's billing practices. To date the Company has produced and delivered to the OIG certain requested information. The OIG to date has not provided the Company with the reason for the subpoena. However, based on conversations with a representative of the OIG and the civil division of the United States Attorney for the Northern District of California, the Company believes the focus of the OIG relates to the Company's procedures surrounding the processing of credit balances relating to its fee-for-service billing volume. Based on these same conversations, the Company believes that the basis for the issuing of this subpoena is a complaint filed by an individual on behalf of the government. The Company is fully cooperating with this request and has been producing and delivering to the OIG the requested documents. However, due to the lack of more specific information available to the Company at this time, we are unable to ascertain the full scope of the government's inquiry. Management believes that its billing practices are in substantial compliance with all regulatory requirements. Nevertheless, management at this time can not predict the outcome of the matter or whether it will have a material adverse effect on the Company's business, financial condition or results of operations. POTENTIAL TAX ASSESSMENT The Company had previously received a Notice of Proposed Adjustment (NOPA) from the Internal Revenue Service (IRS) relating to audits of its federal corporate income tax returns for 2000 and 2001. As the result of receiving a favorable ruling by the Office of the Regional Director of Appeals in connection with the 1999 tax returns of two of its affiliated professional corporations, the Company has subsequently been verbally advised by the local agent that the proposed adjustments for the Company's 2000 and 2001 federal corporate income tax returns have been rescinded. The Company is currently awaiting formal confirmation of the agent's decision by the IRS. NOTE 12. COMPREHENSIVE EARNINGS The components of comprehensive earnings, net of related taxes, are as follows (in thousands):
THREE MONTHS ENDED SIX MONTHS ENDED JUNE 30, JUNE 30, ------------------- ------------------- 2004 2003 2004 2003 --------- ------- -------- -------- Net earnings (loss) attributable to common shareholders............................... $(55,917) $4,078 $(59,555) $(24,292) Net change in fair value of interest rate swaps...................................... (116) (150) 1,034 (204) -------- ------ -------- -------- Comprehensive earnings (loss)................ $(56,033) $3,928 $(58,521) $(24,496) ======== ====== ======== ========
13 ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS INTRODUCTION We are a national provider of outsourced physician staffing and administrative services to hospitals and other healthcare providers in the United States and a provider of outsourced physician staffing and administrative services to military treatment facilities. In addition to providing physician staffing, we also provide a broad array of non-physician health care services, including specialty technical staffing, para-professionals and nurse staffing on a permanent basis to the military. Our regional operating models include comprehensive programs for emergency medicine, radiology, anesthesiology, inpatient care, pediatrics and other health care services, principally within hospital departments and other healthcare treatment facilities. The following discussion provides an assessment of the Company's results of operations, liquidity and capital resources and should be read in conjunction with the consolidated financial statements of the Company and notes thereto included elsewhere in this document. TRICARE PROGRAM During the six months ended June 30, 2004, the Company derived approximately $123.9 million of revenue for services rendered to military personnel and their dependents as a subcontractor under the TRICARE program administered by the Department of Defense. Civilian staffing for the provision of health care services provided under the TRICARE program is provided through several different sources, including the direct hiring of health care related personnel by the military, contracting with managed care support contractors to provide health, medical and administrative support services to its eligible beneficiaries, and through direct contracting with health care staffing organizations. The Company has historically provided its services principally through subcontract arrangements with managed care organizations that have contracted directly with the TRICARE program. On August 1, 2002, the Department of Defense issued a request for proposals for the next generation of managed care support contracts, also known as the "TRICARE Contracts". The intent of the TRICARE Contracts is to replace the existing managed care support contracts on a phased-in basis between June and November 2004. The Department of Defense and its various military branches are currently in the process of procuring the civilian positions that they require going forward. The process of awarding health care staffing contracts by the government to date has varied by branch of the military and by military base location within the various branches of the military. The award process has included soliciting requests for proposals from organizations that provide civilian health care staffing, including the use of restrictive government or military approved vendor lists, some of which do not include the Company. In other instances, the military has re-bid its business on a basis that is inclusive of existing providers, such as the Company, without the use of restricted vendor lists. Furthermore, the awarding of certain bids has been restricted to small business or minority qualified businesses for which the Company is not eligible to even bid for the contracts. As of July 15, 2004, the following is a summary of the Company's military staffing revenues that are subject to re-bidding under the new TRICARE program contracting process (in thousands): Annual revenue derived from contracts subject to re-bidding................................................ $210,700 Amount of revenue re-bid to date............................ $145,200 Amount of annual revenues submitted for re-bidding awarded to date................................................... $132,600 Annual revenue value of bids won to date (including new business of $26.5 million)................................ $ 93,500 Percentage of revenue retained or new business won to total of annual revenue re-bidded and awarded to date........... 71%
The total impact on the results of operations and financial condition of the Company resulting from the changes in the TRICARE Contracts program is not known at this time. The remaining impact on the results 14 of operations of the Company is dependent on the Company's ability to successfully retain its existing staffing business that is still subject to the re-bidding process, as well as winning new business as it is put out to bid by the military. In addition, the Company will experience as a result of the re-bidding process a decline in its operating margin for its military business prior to any reductions in its administrative related expenses. Management has concluded that the Company's existing revenues and operating margins will be materially adversely affected as a result of the re-bidding process. The Company as of June 30, 2004, has $127.9 million of goodwill related to its military staffing business prior to recognition of any impairment loss related to it. Based on the results of the re-bidding process known through July 15, 2004, along with projections of the estimated results of the remaining business to be subject to re-bidding, management has concluded that a portion of such goodwill has been impaired. The Company has recorded an estimated goodwill impairment loss of $65.8 million in the three months ended June 30, 2004. A final determination of the impairment loss will be known following the completion of the re-bidding process which is scheduled to be completed by November 1, 2004. The estimated impairment loss will be adjusted, if necessary, when such final determination is known later in 2004. CRITICAL ACCOUNTING POLICIES AND ESTIMATES The consolidated financial statements of the Company are prepared in accordance with accounting principles generally accepted in the United States, which requires us to make estimates and assumptions. Management believes the following critical accounting policies, among others, affect its more significant judgments and estimates used in the preparation of its consolidated financial statements. REVENUE RECOGNITION Net Revenue. A significant portion (71.9%) of the Company's revenue in the six months ended June 30, 2004, resulted from fee-for-service patient visits. The recognition of net revenue (gross charges less contractual allowances) from such visits is dependent on such factors as proper completion of medical charts following a patient visit, the forwarding of such charts to one of the Company's billing centers for medical coding and entering into the Company's billing systems, and the verification of each patient's submission or representation at the time services are rendered as to the payer(s) responsible for payment of such services. Net revenues are recorded based on the information known at the time of entering of such information into our billing systems as well as an estimate of the net revenues associated with medical charts for a given service period that have not been processed yet into the Company's billing systems. The above factors and estimates are subject to change. For example, patient payer information may change following an initial attempt to bill for services due to a change in payer status. Such changes in payer status have an impact on recorded net revenue due to differing payers being subject to different contractual allowance amounts. Such changes in net revenue are recognized in the period that such changes in payer become known. Similarly, the actual volume of medical charts not processed into our billing systems may be different from the amounts estimated. Such differences in net revenue are adjusted in the following month based on actual chart volumes processed. Net Revenue Less Provision For Uncollectibles. Net revenue less provision for uncollectibles reflects management's estimate of billed amounts to ultimately be collected. Management, in estimating the amounts to be collected resulting from its over six million annual fee-for-service patient visits and procedures, considers such factors as prior contract collection experience, current period changes in payer mix and patient acuity indicators, reimbursement rate trends in governmental and private sector insurance programs, resolution of credit balances, the estimated impact of billing system effectiveness improvement initiatives and trends in collections from self-pay patients. Such estimates are substantially formulaic in nature and are calculated at the individual contract level. The estimates are continuously updated and adjusted if subsequent actual collection experience indicates a change in estimate is necessary. Such provisions and any subsequent changes in estimates may result in adjustments to our operating results with a corresponding adjustment to our accounts receivable allowance for uncollectibles on our balance sheet. Accounts Receivable. As described above and below, we determine the estimated value of our accounts receivable based on estimated cash collection run rates of estimated future collections by contract for patient 15 visits under our fee-for-service contract revenue. Accordingly, we are unable to report the payor mix composition on a dollar basis of our outstanding net accounts receivable. Our days revenue outstanding at June 30, 2004, was 54.1 days and at December 31, 2003, was 61.2 days. The number of days outstanding will fluctuate over time due to a number of factors. The decrease in the average days revenue outstanding of approximately 7.1 days is due to an increase in average revenues per day of approximately 1.3 days, an increase in collections relating to contract accounts receivable due principally to collections on terminated contracts of 2.1 days and increased collections relating to fee-for-service patient visits of approximately 3.7 days. Our allowance for doubtful accounts totaled $130.6 million as of June 30, 2004. Approximately 97% of our allowance for doubtful accounts is related to gross fees for fee-for-service patient visits. Our principal exposure for uncollectible fee-for-service visits is centered in self pay patients and, to a lesser extent, for co-payments and deductibles from patients with insurance. While we do not specifically allocate the fee-for-service allowance for doubtful accounts to individual accounts or specific payor classifications, the allowance related to fee-for-service patients as of June 30, 2004, was approximately 93% of self-pay accounts outstanding as fee-for-service patient visits at June 30, 2004. Primary responsibility for collection of fee-for-service accounts receivable resides within our internal billing operations. Once a claim has been submitted to a payor or an individual patient, employees within our billing operations have responsibility for the follow up collection efforts. The protocol for follow up differs by payor classification. For self pay patients, our billing system will automatically send a series of dunning letters on a prescribed time frame requesting payment or the provision of information reflecting that the balance due is covered by another payor, such as Medicare or a third-party insurance plan. Generally, the dunning cycle on a self pay account will run from 90 to 120 days. At the end of this period, if no collections or additional information is obtained from the patient, the account is no longer considered an active account and is transferred to a collection agency. Upon transfer to a collection agency, the patient account is written-off as a bad debt. Any subsequent cash receipts on accounts previously written off are recorded as a recovery. For non-self pay accounts, billing personnel will follow up and respond to any communication from payors such as requests for additional information or denials until collection of the account is obtained or other resolution has occurred. For contract accounts receivable, invoices for services are prepared in the various operating areas of the Company and mailed to our customers, generally on a monthly basis. Contract terms under such arrangements generally require payment within thirty days of receipt of the invoice. Outstanding invoices are periodically reviewed and operations personnel with responsibility for the customer relationship will contact the customer to follow up on any delinquent invoices. Contract accounts receivable will be considered as bad debt and written-off based upon the individual circumstances of the customer situation after all collection efforts have been exhausted, including legal action if warranted, and it is the judgment of management that the account is not expected to be collected. Methodology for Computing Allowance For Doubtful Accounts. The Company employs several methodologies for determining its allowance for doubtful accounts depending on the nature of the Net Revenue recognized. Fee-for-service Net Revenue Less Provision For Uncollectibles represents the Company's estimated cash to be collected from such patient visits and is estimated based on the factors noted above. The difference between gross net revenue before contractual allowances and Net Revenue Less Provision For Uncollectibles is allocated between provisions for contractual allowances and uncollectible accounts based on historical experience resulting from the adjudication of third-party payor claims or write-off of uncollectible accounts results from the Company's over six million annual patient visits. The significant volume of annual patient visits and the terms of thousands of commercial and managed care contracts and the various reimbursement policies relating to governmental health care programs do not make it feasible to evaluate fee-for-service accounts receivable on a specific account basis. Fee-for-service accounts receivable collection estimates are reviewed on a quarterly basis for each of the Company's fee-for-service contracts by period of accounts receivable origination. Such reviews include the use of historical cash collection percentages by contract adjusted for the lapse of time since the date of the patient visit. In addition, when actual collection percentages differ from expected results, on a contract by contract basis supplemental detailed reviews of the outstanding accounts receivable balances may be performed by our billing operations to determine whether there are facts and circumstances existing that may cause a different conclusion as to the estimate of the collectibility of that contract's accounts receivable from the estimate resulting from using the historical collection experience. Facts and circumstances that may result in an adjustment to the formulaic result are 16 generally few and are usually related to third-party payor processing problems that are temporary in nature. Contract related net revenues are billed based on the terms of the contract at amounts expected to be collected. Such billings are typically submitted on a monthly basis and aged trial balances prepared. Allowances for estimated uncollectible amounts related to such contract billings are made based upon specific accounts and invoice periodic reviews once it is concluded that such amounts are not likely to be collected. The methodologies employed to compute allowances for doubtful accounts were unchanged between 2004 and 2003. INSURANCE RESERVES The nature of the Company's business is such that it is subject to professional liability lawsuits. Historically, to mitigate a portion of this risk, the Company has maintained insurance for individual professional liability claims with per incident and annual aggregate limits per physician for all incidents. Prior to March 12, 2003, such insurance coverage has been provided by a commercial insurance company provider. Professional liability lawsuits are routinely reviewed by the Company's insurance carrier and management for purposes of establishing ultimate loss estimates. Provisions for estimated losses in excess of insurance limits have been provided at the time such determinations are made. In addition, where as a condition of a professional liability insurance policy the policy includes a self-insured risk retention layer of coverage, the Company has recorded a provision for estimated losses likely to be incurred during such periods and within such limits based on its past loss experience following consultation with its outside insurance experts and claims managers. Subsequent to March 11, 2003, the Company has provided for a significant portion of its professional liability loss exposures through the use of a captive insurance company and through greater utilization of self-insurance reserves. Accordingly, beginning on March 12, 2003, a substantial portion of the Company's provision for professional liability losses is based on periodic actuarially determined estimates of such losses for periods subsequent to March 11, 2003. An independent actuary firm is responsible for preparation of the periodic actuarial studies. Management's estimate of the Company's professional liability costs resulting from such actuarial studies is significantly influenced by assumptions, which are limited by the uncertainty of predicting future events, and assessments regarding expectations of several factors. These factors include, but are not limited to: the frequency and severity of claims, which can differ significantly by jurisdiction; coverage limits of third-party insurance; the effectiveness of the Company's claims management process; and the outcome of litigation. The Company's commercial insurance policy for professional liability losses for the period March 12, 1999 through March 11, 2003, included insured limits applicable to such coverage in the period. The Company in March 2003 had an actuarial projection made of its potential exposure for losses under the provisions of its commercial insurance policy that ended March 11, 2003. The results of that actuarial study indicated that the Company would incur a loss for claim losses and expenses in excess of the $130.0 million aggregate limit. Accordingly, the Company recorded a loss estimate, discounted at 4%, of $50.8 million in its statement of operations for the three months ended March 31, 2003. The payment of any losses realized by the Company under the aggregate loss provision discussed above will only be after the Company's previous commercial insurance carrier has paid such losses and expenses up to $130.0 million for the applicable prior periods. The pattern of payment for professional liability losses for any incurrence year typically is as long as six years. Accordingly, the Company's portion of its loss exposure under the aggregate policy feature, if realized, is not expected to result in a cash outflow in 2004. Since March 12, 2003, the Company's professional liability costs consist of annual projected costs resulting from an actuarial study along with the cost of certain professional liability commercial insurance premiums and programs available to the Company that remain in effect. The provisions for professional liability costs will fluctuate as a result of several factors, including hours of exposure as measured by hours of physician and related professional staff services as well as actual loss development trends. As noted above, due to the long pattern of payout for such exposures, the Company anticipates that a substantial portion of such 17 latter amount will not be realized in the form of actual cash outlays from the Company's captive insurance subsidiary until periods beyond 2004. The Company's provisions for losses under the aggregate loss limits of its policy in effect prior to March 12, 2003, and under its captive insurance and self-insurance programs since March 12, 2003, are subject to periodic actuarial reevaluation. The results of such periodic actuarial studies may result in either upward or downward adjustment to the Company's previous loss estimates. IMPAIRMENT OF INTANGIBLE ASSETS In assessing the recoverability of the Company's intangibles the Company must make assumptions regarding estimated future cash flows and other factors to determine the fair value of the respective assets. If these estimates or their related assumptions change in the future, the Company may be required to record impairment charges for these assets. The Company's critical accounting policies have been disclosed in its 2003 Annual Report on Form 10-K Equivalent. There have been no changes to these critical accounting policies or their application during the six months ended June 30, 2004. RESULTS OF OPERATIONS The following discussion provides an analysis of our results of operations and should be read in conjunction with our unaudited consolidated financial statements. The operating results of the periods presented were not significantly affected by general inflation in the U.S. economy. Net revenue less the provision for uncollectibles is an estimate of future cash collections and as such it is a key measurement by which management evaluates performance of individual contracts as well as the Company as a whole. The following table sets forth the components of net loss as a percentage of net revenue less provision for uncollectibles for the periods indicated:
THREE MONTHS ENDED SIX MONTHS ENDED JUNE 30, JUNE 30, ------------------ ---------------- 2004 2003 2004 2003 ------ ------ ----- ----- Net revenue.................................... 151.9% 143.5% 151.9% 145.1% Provision for uncollectibles................... 51.9 43.5 51.9 45.1 Net revenue less provision for uncollectibles............................... 100.0 100.0 100.0 100.0 Professional services expenses................. 74.7 74.8 74.6 75.5 Professional liability costs................... 5.3 5.8 5.8 15.6 Gross profit................................... 20.0 19.4 19.6 8.9 General and administrative expenses............ 9.4 9.8 9.4 9.4 Management fee and other expenses.............. 0.2 0.1 0.1 0.1 Depreciation and amortization.................. 1.4 2.2 1.3 2.3 Interest expense, net.......................... 2.7 2.5 2.8 2.5 Refinancing costs.............................. -- -- 2.8 -- Estimated impairment loss...................... 25.7 -- 12.7 -- Earnings (loss) before income taxes............ (19.4) 4.8 (9.6) (5.4) Provision (benefit) from income taxes.......... 2.4 1.8 1.2 (1.9) Net earnings (loss)............................ (21.8) 3.0 (10.8) (3.5) Dividends on preferred stock................... -- 1.4 0.7 1.5 Net earnings (loss) attributable to common stockholders................................. (21.8) 1.6 (11.5) (5.0)
18 THREE MONTHS ENDED JUNE 30, 2004 COMPARED TO THE THREE MONTHS ENDED JUNE 30, 2003 Net Revenues. Net revenues for the three months ended June 30, 2004 increased $29.8 million, or 8.3%, to $388.7 million from $359.0 million for the three months ended June 30, 2003. The increase in net revenues of $29.8 million included an increase of $34.7 million in fee-for-service revenue, offset by decreases in contract revenue of $3.9 million and $1.0 million in other revenue. For the three month periods ended June 30, 2004 and 2003, fee-for-service revenue was 72.1% of net revenue in 2004 compared to 68.4% in 2003, contract revenue was 25.9% of net revenue in 2004 compared to 29.2% in 2003 and other revenue was 2.0% of net revenue in 2004 compared to 2.4% in 2003. Provision for Uncollectibles. The provision for uncollectibles was $132.7 million for the three months ended June 30, 2004 compared to $108.8 million for the three months ended June 30, 2003, an increase of $23.9 million or 21.9%. The provision for uncollectibles as a percentage of net revenue was 34.1% for the three months ended June 30, 2004 compared to 30.3% for the three months ended June 30, 2003. The provision for uncollectibles is primarily related to revenue generated under fee-for-service contracts that is not expected to be fully collected. The increase in the provision for uncollectibles resulted from fee schedule and average acuity pricing increases in excess of increased average collection rates for self-pay patients. During the three months ended June 30, 2004, a provision totaling $0.9 million related to a contract receivable from a financially troubled hospital client for which collection is now doubtful was also recorded. In addition to the aforementioned factors, the increase in the provision for uncollectibles as a percentage of revenues was affected by an estimated 0.4% payer mix shift toward more self-pay patient encounters in 2004. Net Revenue Less Provision for Uncollectibles. Net revenue less provision for uncollectibles for the three months ended June 30, 2004 increased $5.9 million, or 2.3%, to $256.0 million from $250.1 million for the corresponding three months in 2003. The increase between periods was primarily due to an increase in same contract revenue. Same contract revenue less provision for uncollectibles, which consists of contracts under management in both periods, increased $5.1 million, or 2.2%, to $229.6 million in 2004 from $224.6 million in 2003. The increase in same contract revenue of 2.2% includes the net effect of higher estimated net revenue per billing unit offset by decreased overall dollar volume between periods. Same contract revenue increased approximately 3.9% between periods due to higher estimated net revenue per billing unit. While same contract fee-for-service volumes increased approximately 1.0% between periods, contract revenues declined due to lower billable hours in the Company's locum tenens and radiology staffing contract based services, principally as a result of terminating certain operating services and contracts in those staffing areas. A decline in other revenue of approximately $1.0 million between years is principally due to favorable managed care payer settlements received in 2003 totaling $1.2 million related to disputed billings on prior years' claims. Professional Service Expenses. Professional service expenses, which includes physician costs, billing and collection expenses and other professional expenses, totaled $191.2 million for the three months ended June 30, 2004 compared to $187.0 million for the three months ended June 30, 2003, an increase of $4.2 million or 2.3%. The increase of $4.2 million in professional service expenses included approximately $2.2 million resulting from increases in steady state contract costs. The increase of approximately $2.2 million resulted principally from increases in average rates paid per hour of provider service on a same contract basis. Professional Liability Costs. Professional liability costs were $13.6 million in 2004 compared with $14.5 million in 2003 for a decrease of $0.9 million. The decrease in professional liability expenses includes the reduction of $2.0 million of self-insured retention reserves for excess limits provided to certain physicians in prior years as a result of a review of remaining outstanding claims and estimated loss exposures there under. A review of remaining outstanding claims resulted in the conclusion that such claims are now more likely than not to be settled within policy limits. Gross Profit. Gross profit was $51.1 million for the three months ended June 30, 2004, compared to $48.6 million in 2003. The increase in gross profit is attributable to an increased contribution from steady state contracts (including the $2.0 million reduction in certain professional liability reserves) partially offset by lower gross profit due to terminated contracts between periods. Gross profit as a percentage of revenue less 19 provision for uncollectibles for the three months ended June 30, 2004 was 20.0% compared to 19.4% for the three months ended June 30, 2003. General and Administrative Expenses. General and administrative expenses for the three months ended June 30, 2004 decreased to $24.1 million from $24.4 million for the three months ended June 30, 2003, for a decrease of $0.3 million between periods or 1.4%. General and administrative expenses as a percentage of net revenue less provision for uncollectibles were 9.4% for the three months ended June 30, 2004, compared to 9.8% for the three months ended June 30, 2003. The decrease in general and administrative expenses between years was principally due to decreases in management incentive costs of approximately $1.4 million and in legal and consulting costs of approximately $0.7 million related to a disputed contract settlement in 2003, offset by increases in salaries and benefits of $1.4 million and an increase of $0.9 million for professional consulting expenses relating to improving our billing and collection processes. Management Fee and Other Operating Expenses. Management fee and other operating expenses were $0.5 million for the three months ended June 30, 2004 and $0.1 million for the corresponding period in 2003. Other operating expenses in 2004 included a loss on asset disposal totaling $0.3 million. Estimated Impairment Loss. During the three months ended June 30, 2004, an estimated impairment loss in the amount of $65.8 million was recorded related to goodwill associated with our military staffing business. The results of the re-bidding of our healthcare staffing contracts under the military's Tricare Program to date has indicated a net loss of contract revenues and margin related to such staffing services. Based on the results of the re-bidding to date and an estimate of contract re-bidding still to occur through November 1, 2004, an impairment analysis using expected future cash flows and estimated fair market values relating to the underlying business to which the goodwill applies indicated that the goodwill previously recorded in the amount of $127.9 million was impaired. The estimated impairment loss recorded of $65.8 million is subject to further adjustment and finalization following completion of the military's re-bidding process now scheduled to be completed by November 1, 2004. Depreciation and Amortization. Depreciation and amortization was $3.5 million for the three months ended June 30, 2004 and $5.6 million for the three months ended June 30, 2003. Amortization expense decreased by $1.9 million between periods due to certain of the Company's intangibles becoming fully amortized in 2003. Net Interest Expense. Net interest expense increased $0.8 million to $7.0 million for the three months ended June 30, 2004 compared to $6.2 million for the corresponding period in 2003. The increase in net interest expense includes approximately $2.2 million due to an increased level of net outstanding debt between periods, partially offset by lower interest rates between periods. Earnings (Loss) before Income Taxes. Loss before income taxes for the three months ended June 30, 2004, was a loss of $49.7 million compared to earnings of $12.2 million for the three months ended June 30, 2003. Provision for Income Taxes. Provision for income taxes for the three months ended June 30, 2004 was $6.2 million compared to $4.6 million for the three months ended June 30, 2003. Net Earnings (Loss). Net loss for the three months ended June 30, 2004 was a loss of $55.9 million compared to net earnings of $7.7 million for the three months ended June 30, 2003. Dividends on Preferred Stock. In the three months ended June 30, 2003, we incurred $3.6 million of dividends on our then outstanding Class A mandatory redeemable preferred stock. SIX MONTHS ENDED JUNE 30, 2004 COMPARED TO THE SIX MONTHS ENDED JUNE 30, 2003 Net Revenues. Net revenues for the six months ended June 30, 2004 increased $76.9 million, or 10.8%, to $786.0 million from $709.1 million for the six months ended June 30, 2003. The increase in net revenues of $76.9 million included an increase of $73.2 million in fee-for-service revenue and $4.4 million in contract revenue offset by a decrease of $0.7 million in other revenue. For the six month periods ended June 30, 2004 and 2003, fee-for-service revenue was 71.9% of net revenue in 2004 compared to 69.4% in 2003, contract 20 revenue was 26.2% of net revenue in 2004 compared to 28.4% in 2003 and other revenue was 1.9% of net revenue in 2004 compared to 2.2% in 2003. Provision for Uncollectibles. The provision for uncollectibles was $268.6 million for the six months ended June 30, 2004 compared to $220.6 million for the six months ended June 30, 2003, an increase of $48.0 million or 21.8%. The provision for uncollectibles as a percentage of net revenue was 34.2% for the six months ended June 30, 2004 compared to 31.1% for the six months ended June 30, 2003. The provision for uncollectibles is primarily related to revenue generated under fee-for-service contracts that is not expected to be fully collected. The increase in the provision for uncollectibles percentage resulted from fee schedule and average acuity pricing increases in excess of increased average collection rates for self-pay patients. In addition, the increase in the provision for uncollectibles as a percentage of revenue was affected by an estimated 0.9% payer mix shift toward more self-insured patient encounters in 2004. Net Revenue Less Provision for Uncollectibles. Net revenue less provision for uncollectibles for the six months ended June 30, 2004 increased $28.9 million, or 5.9%, to $517.4 million from $488.5 million for the corresponding six months in 2003. Same contract revenue less provision for uncollectibles, which consists of contracts under management in both periods, increased $23.7 million, or 5.6%, to $447.6 million in 2004 from $423.9 million in 2003. The increase in same contract revenue of 5.6% is principally due to increased net revenue per billing unit as patient volumes increased less than 1% between periods. Acquisitions contributed $3.5 million and new contracts obtained through internal sales contributed $39.3 million of the increase. The aforementioned increases were partially offset by $37.7 million of revenue derived from contracts that terminated during the periods. A decline in other revenue of approximately $0.7 million between periods is principally due to favorable managed care settlements totaling $1.2 million received in 2003 related to disputed billings on prior years' claims. Professional Service Expenses. Professional service expenses, which includes physician costs, billing and collection expenses and other professional expenses, totaled $385.9 million for the six months ended June 30, 2004 compared to $369.0 million for the six months ended June 30, 2003, an increase of $16.9 million or 4.6%. The increase of $16.9 million in professional service expenses included approximately $4.7 million resulting from acquisitions and net growth in new contract sales. The remaining increase of approximately $12.2 million resulted principally from increases in average rates paid per hour of provider service on a same contract basis. Professional Liability Costs. Professional liability costs were $29.9 million in 2004 compared with $76.1 million in 2003 for a decrease of $46.2 million. The decrease in professional liability expenses is due primarily to a provision for losses in excess of an aggregate insured limit for periods prior to March 12, 2003 of $50.8 million in 2003. Excluding the $50.8 million provision, professional liability expenses increased $4.6 million between periods. The Company's cost of professional liability insurance in 2004 is based on an actuarial estimate of losses under the Company's captive insurance program. In 2003, such costs reflected premium costs under a premium based commercial insurance program in effect through March 11, 2003, with actuarial estimates of losses under the Company's self-insurance program thereafter. The increase of $4.6 million is net of the reduction of $2.0 million in 2004 of self-insured retention reserves for excess limits provided for certain physicians in prior years as a result of a review of remaining outstanding claims pertaining to such coverage periods and approximately $1.6 million in 2004 resulting from favorable actuarial results related to 2003 initial self-insured loss year reserves. Gross Profit. Gross profit was $101.6 million for the six months ended June 30, 2004, compared to $43.5 million in 2003. The increase in gross profit is attributable to the effect of the aggregate provision for professional liability insurance losses of $50.8 million in 2003 and increased contribution from steady state operations. Gross profit as a percentage of revenue less provision for uncollectibles for the six months ended June 30, 2004 was 19.6% compared to 19.3% before the provision for excess losses for the six months ended June 30, 2003. General and Administrative Expenses. General and administrative expenses for the six months ended June 30, 2004 increased to $48.8 million from $45.9 million for the six months ended June 30, 2003, for an increase of $2.9 million between periods. General and administrative expenses as a percentage of net revenue less provision for uncollectibles were 9.4% in both periods. Included in general and administrative expenses in 21 2004 is approximately $1.3 million related to a bonus paid to stock option holders in connection with a refinancing of the Company's debt structure. Excluding the effect of the stock option bonus expense, general and administrative expenses increased approximately $1.6 million, or 3.5%. The remaining increase in general and administrative expenses between years was principally due to increases in salaries and benefits of approximately $1.8 million and $1.7 million for professional consulting expenses related to improving our billing and collection processes partially offset by nonrecurring costs related to a legal settlement in 2003 of $0.7 million and a decrease in cost of approximately $1.2 million under our management incentive plan. Management Fee and Other Operating Expenses. Management fee and other operating expenses were $0.6 million for the six months ended June 30, 2004 and $0.3 million for the corresponding period in 2003. Other operating expenses in 2004 included a loss on asset disposal totaling $0.3 million. Estimated Impairment Loss. During the six months ended June 30, 2004, an estimated impairment loss in the amount of $65.8 million was recorded related to goodwill associated with our military staffing business. The results of the re-bidding of our healthcare staffing contracts under the military's Tricare Program to date has indicated a net loss of contract revenues and margin related to such staffing services. Based on the results of the re-bidding to date and an estimate of contract re-bidding still to occur through November 1, 2004, an impairment analysis using expected future cash flows and estimated fair market values relating to the underlying business to which the goodwill applies indicated that the goodwill previously recorded in the amount of $127.9 million was impaired. The estimated impairment loss recorded of $65.8 million is subject to further adjustment and finalization following completion of the military's re-bidding process now scheduled to be completed by November 1, 2004. Depreciation and Amortization. Depreciation and amortization was $6.9 million for the six months ended June 30, 2004 and $11.1 million for the six months ended June 30, 2003. Amortization expense decreased by $3.8 million between periods due to certain of the Company's intangibles becoming fully amortized in 2003. Net Interest Expense. Net interest expense increased $1.9 million to $14.3 million for the six months ended June 30, 2004, compared to $12.4 million for the corresponding period in 2003. The increase in net interest expense includes approximately $2.6 million due to an increased level of net outstanding debt between periods and a realized hedge instrument loss of approximately $1.3 million in 2004 partially offset by lower interest rates and non-cash amortization of loan costs between periods. Refinancing Costs. The Company expensed $14.7 million of deferred financing costs and bond repayment premiums related to its previously outstanding bank and bond borrowings that were refinanced in 2004. Loss before Income Taxes. Loss before income taxes for the six months ended June 30, 2004 was $49.7 million compared to $26.2 million for the six months ended June 30, 2003. Provision (Benefit) for Income Taxes. Provision for income taxes for the six months ended June 30, 2004 was $6.3 million compared to a benefit of $9.1 million for the six months ended June 30, 2003. Net Loss. Net loss for the six months ended June 30, 2004 was $56.0 million compared to a net loss of $17.1 million for the six months ended June 30, 2003. Dividends on Preferred Stock. The Company recognized $3.6 million of dividends for the six months ended June 30, 2004 and $7.2 million for the six months ended June 30, 2003, on its Class A mandatory redeemable preferred stock. LIQUIDITY AND CAPITAL RESOURCES Our principal ongoing uses of cash are to meet working capital requirements, fund debt obligations and to finance our capital expenditures and acquisitions. Funds generated from operations during the past two years, with the exception of the acquisition of a provider of medical staffing to military treatment facilities on May 1, 2002, have been sufficient to meet the aforementioned cash requirements. 22 In 2004, we restructured our capital structure. The restructuring resulted in the following transactions occurring: - Our Board of Directors authorized the redemption of our 10% Cumulative Preferred Stock in the amount of approximately $162.4 million, including accrued dividends. - We completed a tender offer for our outstanding 12% Senior Subordinated Notes resulting in $100.0 million of such bonds being repaid, plus payment of a call premium of $8.2 million. - We issued new 9% Senior Subordinated Notes in the amount of $180.0 million. - We retired our existing bank debt in the amount of $199.4 million and entered into a new senior bank credit facility, including a $250.0 million senior secured term loan and an $80.0 million revolving credit facility. - We incurred and paid approximately $7.8 million in costs through June 30, 2004 (in addition to an $8.2 million call premium on our previously outstanding 12% Senior Subordinated Bonds) to complete the above transactions. In addition, the Board of Directors declared and paid to our shareholders a cash dividend of approximately $27.6 million on March 23, 2004. The Board of Directors also authorized a cash payment to holders of stock options in the form of a compensatory bonus in the approximate amount of $1.3 million. As a result of the above transactions, we have total debt outstanding of $429.4 million as of June 30, 2004, compared to $299.4 million as of December 31, 2003 Cash provided from operating activities in the six months ended June 30, 2004 was $21.4 million compared to cash provided by operating activities in the corresponding period in 2003 of $11.7 million. The $9.7 million increase in cash provided by operating activities was principally due to an increase in cash collections on accounts receivable as well as net cash retained under a self-insured professional liability insurance program. Cash provided from investing activities in the six months ended June 30, 2004, was $2.6 million compared to a use of cash in 2003 of $10.3 million. The $12.9 million increase in cash provided by investing activities was principally due to the redemption of assets held in a deferred compensation plan which were liquidated as part of the refinancing, as well as reduced levels of capital expenditures in 2004. Cash used in financing activities in the six months ended June 30, 2004 and 2003 was $70.0 million and $15.1 million, respectively. The $54.9 million decrease in cash resulting from financing activities was due to the debt restructuring and dividend paid in 2004. We spent $2.6 million in the first six months of 2004 and $5.9 million in the first six months of 2003 for capital expenditures. These expenditures were primarily for information technology investments and related development projects. We have historically been an acquirer of other physician staffing businesses and interests. Such acquisitions in recent years have been completed for cash. Cash payments made in connection with acquisitions, including contingent payments, were $2.3 million during the six months ended June 30, 2004 and $1.6 million in the corresponding period in 2003. Future contingent payment obligations are approximately $8.4 million as of June 30, 2004. We made scheduled debt maturity payments of $0.6 million in the first six months of 2004 in accordance with its applicable term loan facilities in effect at the time. We began providing effective March 12, 2003, for professional liability risks in part through a captive insurance company. Prior to such date we insured such risks principally through the commercial insurance market. The change in the professional liability insurance program has resulted in increased cash flow due to the retention of cash formerly paid out in the form of insurance premiums to a commercial insurance company coupled with a long period (typically 2-4 years or longer on average) before cash payout of such losses occurs. A portion of such cash retained will be retained within our captive insurance company and therefore not immediately available for general corporate purposes. As of June 30, 2004, cash or cash equivalents and related investments held within the captive insurance company totaled approximately $21.5 million. Based on 23 the results of our most recent actuarial report and renewal of our fronting carrier program effective June 1, 2004, anticipated cash outflow to the captive insurance company and to its third-party fronting carrier during the period July 1, 2004 through May 31, 2005, is estimated at $23.9 million. Our senior credit facility at June 30, 2004 provides for up to $80.0 million of borrowings under a senior revolving credit facility and $250.0 million of term loans. Borrowings outstanding under the senior credit facility mature in various years with a final maturity date of March 31, 2011. The senior credit facility agreement contains both affirmative and negative covenants, including limitations on our ability to incur additional indebtedness, sell material assets, retire, redeem or otherwise reacquire its capital stock, acquire the capital stock or assets of another business, pay dividends, and requires us to meet or exceed certain coverage, leverage and indebtedness ratios. The senior credit agreement also includes a provision for the prepayment of a portion of the outstanding term loan amounts at any year-end if we generate "excess cash flow," as defined in the agreement. Approximately $210.7 million of annual revenue resulting from providing staffing services to the military has been subjected to a re-bidding process with awards effective at various dates between June 1 and November 1, 2004. Based on awards related to approximately $132.6 million of such annual revenue, we have been successful in winning existing or new business contracts of approximately $93.5 million in annual revenues or 71% of our annual revenue that has been re-bid and awarded to date. In addition, the operating margins expected to be realized from such awards have generally been lower than existing margins. Based on the results of the re-bidding awards to date and management's expectations of future awards, we expect a decline beginning in the second half of 2004 in annual earnings and cash flow from our military staffing business. We do not expect the decline in earnings and cash flow from its military staffing business, based on our estimates of such earnings and cash flow, to result in any violations of debt covenant financial ratio requirements under our senior credit agreement. We had as of June 30, 2004, total cash and cash equivalents of approximately $55.0 million and a revolving credit facility borrowing availability of $76.1 million. Our ongoing cash needs in the six months ended June 30, 2004 were met from internally generated operating sources and there were no borrowings under our revolving credit facility. We believe that our cash needs, other than for significant acquisitions, will continue to be met through the use of its remaining existing available cash, cash flows derived from future operating results and cash generated from borrowings under our senior revolving credit facility. INFLATION We do not believe that general inflation in the U.S. economy has had a material impact on our financial position or results of operations. SEASONALITY Historically, our revenues and operating results have reflected minimal seasonal variation due to the significance of revenues derived from patient visits to emergency departments, which are generally open on a 365 day basis, and also due to our geographic diversification. Revenue from our non-emergency department staffing lines is dependent on a healthcare facility being open during selected time periods. Revenue in such instances will fluctuate depending upon such factors as the number of holidays in the period. RECENTLY ISSUED ACCOUNTING STANDARDS None. ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK The Company is exposed to market risk related to changes in interest rates. The Company does not use derivative financial instruments for speculative or trading purposes. 24 The Company's earnings are affected by changes in short-term interest rates as a result of its borrowings under its senior credit facilities. Interest rate swap agreements are used to manage a portion of the Company's interest rate exposure. The Company was obligated under the terms of its senior credit facility agreement to obtain within 90 days of the date of entering into the agreement interest rate hedge agreements at amounts such that 50% of the Company's funded debt, as defined, was at fixed rates of interest. Such hedge agreements are required to be maintained for at least the first three years of the senior credit facility agreement. On April 29, 2004, the Company entered into an interest rate swap agreement that effectively converted $35.0 million of its variable rate Term Loan B to a fixed rate of 3.2% through March 31, 2007. The agreement is a contract to exchange, on a quarterly basis, floating interest rate payments based on the eurodollar rate, for fixed interest rate payments over the life of the agreement. This agreement exposes the Company to credit losses in the event of non-performance by the counterparty to the financial instrument. The counterparty to the Company's interest rate swaps agreement is a creditworthy financial institution and the Company believes the counterparty will be able to fully satisfy its obligations under the contracts. The Company had previously entered into a forward interest rate swap agreement effective November 7, 2002, to effectively convert $62.5 million of floating-rate borrowings to 3.86% fixed-rate borrowings. The contract had a final expiration date of April 30, 2005. As a result of the payment of the underlying borrowings in 2004, the Company realized a loss of approximately $1.7 million related to this interest rate hedge agreement to reflect its value on a mark to market basis. At June 30, 2004, the fair value of the Company's total debt, which has a carrying value of $429.4 million, was approximately $424.9 million. The Company had $249.4 million of variable debt outstanding at June 30, 2004. If the market interest rates for the Company's variable rate borrowings averaged 1% more during the twelve months subsequent to June 30, 2004, the Company's interest expense would increase, and earnings before income taxes would decrease, by approximately $2.5 million. This analysis does not consider the effects of the reduced level of overall economic activity that could exist in such an environment. Further, in the event of a change of such magnitude, management could take actions to further mitigate its exposure to the change. However, due to the uncertainty of the specific actions that would be taken and their possible effects, the sensitivity analysis assumes no changes in the Company's financial structure. ITEM 4. CONTROLS AND PROCEDURES (a) The Company carried out an evaluation, under the supervision and with the participation of the Company's management, including the Company's Chairman and Chief Executive Officer along with the Company's Executive Vice President of Finance and Administration, of the effectiveness of the design and operation of the Company's disclosure controls and procedures as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Based upon that evaluation the Company's Chief Executive Officer along with the Company's Executive Vice President of Finance and Administration concluded that as of the end of the period covered by this report the Company's disclosure controls and procedures (1) were effective in timely alerting them to material information relating to the Company (including its consolidated subsidiaries) required to be included in the Company's periodic SEC filings and (2) were adequate to ensure that information required to be disclosed by the Company in the reports filed or submitted by the Company under the Exchange Act is recorded, processed and summarized and reported within the time periods specified in the SEC's rules and forms. (b) There have been no significant changes in the Company's internal control over financial reporting identified in connection with the evaluation described in paragraph (a) above, that have materially affected or are reasonably likely to materially affect, the Company's internal control over financial reporting. 25 PART 2. OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS Team Health is a party to various pending legal actions arising in the ordinary operation of its business such as contractual disputes, employment disputes and general business actions as well as malpractice actions. Team Health does not believe that the results of such legal actions, individually or in the aggregate, will have a material adverse effect on the Company's business or its results of operations, cash flows or financial condition. See note 11 to the consolidated financial statements for a description of legal actions to which we are party. ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS None. ITEM 3. DEFAULTS UPON SENIOR SECURITIES None. ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS None. ITEM 5. OTHER INFORMATION None. ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K (a) Exhibits 31.1 Certification by Lynn Massingale, M.D. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. 31.2 Certification by Robert J. Abramowski pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
(b) Reports of Form 8-K On April 6, 2004, the Company furnished a Report on Form 8-K relating to the announcement of the extension of the consent date with respect to its tender offer for any and all of its $100.0 million aggregate principal amount of 12% Senior Subordinated Notes due 2009. On April 6, 2004, the Company furnished a Report on Form 8-K relating to the announcement of the completion of its cash tender offer and consent solicitation for any and all of its $100.0 million aggregate principal amount of 12% Senior Subordinated Notes due 2009. On May 24, 2004, the Company furnished a Report on Form 8-K announcing its earnings for the quarter ended March 31, 2004. 26 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 10-Q Equivalent to be signed on its behalf by the undersigned thereunto duly authorized in the City of Knoxville, Tennessee. TEAM HEALTH, INC. /s/ H. LYNN MASSINGALE, M.D. August 10, 2004 -------------------------------------- H. Lynn Massingale Chief Executive Officer /s/ ROBERT J. ABRAMOWSKI August 10, 2004 -------------------------------------- Robert J. Abramowski Executive Vice President Finance and Administration /s/ DAVID P. JONES August 10, 2004 -------------------------------------- David P. Jones Chief Financial Officer 27